Is a complete FRA/H1Z research report available?

No complete published report is available for fra/H1Z (FRA/H1Z) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/H1Z (FRA/H1Z)

Frankfurt Stock Exchange: FRA/H1Z · EUR

€0.40

-0.05 (-11.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/H1Z analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	14.6M
Net income (ttm)	-9.5M
EPS (ttm)	-€0.37
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -9.5M
EPS (ttm): -€0.37
Market cap: 14.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-07-31 02:00 UTC

All FRA/H1Z indicators

Market & fundamental data

Available fields

127

Groups with data

Currency

USD

Showing 127 of 127 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	DE
Employees	17
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 14.6M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-07-18
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 14.6M
Price	EUR 0.4
Price currency	EUR
Sic	2836
Symbol	fra/H1Z
Website	https://www.neurosense-tx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-64.79%
FCF yield	-44.72%
P/B ratio	-11.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -9.5M
Profit Per Employee	EUR -557,363
ROA	-247.3
Roa5y	-128.9
ROCE	745
ROE	-2,175
Roe5y	-1,071.2
ROIC	-1,094.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-76.73%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 875,548
Cash	EUR 141,382
Current Assets	EUR 674,855
Current Liabilities	EUR 2.2M
Debt	EUR 144,789
Debt FCF	EUR -0.02
Equity	EUR -1.3M
Liabilities	EUR 2.2M
Long Term Assets	EUR 200,693
Long Term Liabilities	EUR 21,764
Net Cash	EUR -3,407
Net Cash By Market Cap	EUR -0.02
Tangible Book Value	EUR -1.3M
Tangible Book Value Per Share	EUR -0.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.31
Net Working Capital	EUR -1.5M
Quick ratio	0.08
Working Capital	EUR -1.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-36.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-76.71%
200-day SMA	0.7
50-day SMA	0.59
50-day SMA vs 200-day SMA	50under200
All Time High	2.14
All Time High Change	-81.5%
All Time High Date	2025-06-12
All Time Low	0.4
All Time Low Change	0%
All Time Low Date	2026-07-30
ATR	0.03
Ch YTD	-31.72
High	0.4
High52	1.57
High52 Date	2025-07-30
High52ch	-74.78%
Low	0.4
Low52	0.4
Low52 Date	2026-07-30
Low52ch	0%
Ma50ch	-32.56%
Price vs 200-day SMA	-43.57%
RSI	33.12
RSI Monthly	42.27
RSI Weekly	34.28
Sharpe ratio	-0.43x
Sortino ratio	-0.63
Total Return	-36.98%
Tr YTD	-31.72
Tr1m	-35.08%
Tr1w	-22.35%
Tr3m	-37.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -9.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,343,452%
Shares Insiders	33.96%
Shares Institutions	1.01%
Shares Qo Q	0%
Shares Yo Y	36.98%
Short Ratio	3.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -8.4M
Adjusted OCF	-8,356,029
Average Volume	97.5x
Bv Per Share	-0.04
CAPEX	EUR -6,814
Ch1m	-35.08
Ch1w	-22.35
Ch1y	-76.71
Ch3m	-37.64
Ch6m	-44.62
Change	-11.21%
Change From Open	0
Close	0.45
Days Gap	-11.21
Depreciation Amortization	13,878.8
Earnings Date	2026-07-31
EBIT	EUR -9.4M
EBITDA	EUR -9.4M
EPS	EUR -0.37
F Score	1
FCF	EUR -6.5M
FCF EV Yield	-44.71x
Financing CF	3,774,734
Fiscal Year End	December
Founded	2,017
Investing CF	-6,814
Is Primary Listing	0
Last Report Date	2025-12-31
Ma150	0.65
Ma150ch	-38.86%
Ma20	0.54
Ma20ch	-26.86%
Net CF	-2,735,660
Next Earnings Date	2026-07-31
Open	0.4
Ppne	197,772.4
Price Date	2026-07-30
Share Based Comp	1,822,638
Tr6m	-44.62%
Volume	0

FRA/H1Z (FRA/H1Z)

Coverage state: Market snapshot only — no published research

Generate the first FRA/H1Z analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/H1Z

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/H1Z indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/H1Z

Frequently asked questions